GC-MS analysis of ethanolic extract of Momordica charantia fruit
Abstract
Researchers are particularly interested in medicinal plants because most pharmaceutical businesses use them to make pharmaceutical compounds. Traditionally, especially in India, a large number of compounds utilized as food colors, tastes, perfumes, and medicinal biochemicals are obtained from plants. Most herbal treatments and their derivative products were often made from crude plant extracts, which are a complex mixture of various phytochemical constituents (plant secondary metabolites). The chemical properties of these components differ greatly between species. The GC-MS method employed for the study of the extracted materials is an interesting instrument for figuring out the concentration of specific active principles in herbs used in the food, pharmaceutical, cosmetic, or pharmaceutical industries. The aim of this work was to discover bioactive compounds from the ethanolic fruit extract of Momordica charantia using gas chromatography and mass spectrometry (GC-MS). The GCMS-QP2010 Ultra Version was used to perform GCMS analysis of the ethanolic extract in accordance with standard procedure. The findings demonstrated the presence of various 32 phytochemicals, including heptacosanoic acid, Eicosanoic acid,Eicosanoic acid, Undecanoic acid, docanoic acid, decanal, 1-(Pyrrolidin-3-yl) pyrazole, Tricotanoic acid in the ethanolic extract of M. charantia. Because of the ethanolic extract contains secondary metabolites, the M. charantia may have anti-inflammatory, Antifungal, neurological disorders, anti-tumor, anti-microbial, antioxidant, and antidiabetic properties. These results support the traditional use of M. charantia for a number of ailments. Further research is needed to determine the extract's active ingredient and elucidate its exact method of action in a range of ailments.
Keywords: 1-(Pyrrolidin-3-yl) pyrazole, M. charantia, Heptacosanoic acid, Eicosanoic acid, Decanal
Keywords:
1-(Pyrrolidin-3-yl) pyrazole, M. charantia, Heptacosanoic acid, Eicosanoic acid, DecanalDOI
https://doi.org/10.22270/jddt.v16i7.7858References
1. Bharathi LK, & John KJ, “Momordica genus in Asia - An Overview” Springer Nature, 2013.
2. Grover JK, Yadav SP, “Pharmacological actions and potential uses of Momordica charantia: a review” J Ethnopharmacol, 2004; Jul; 93(1):123-32. DOI: https://doi.org/10.1016/j.jep.2004.03.035
3. Raman A, Lau C, “Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae)” Phytomedicine, 1996; Mar; 2(4):349-62. DOI: https://doi.org/10.1016/S0944-7113(96)80080-8
4. Bailey CJ, Day C, Leather dale BA, “Traditional treatments for diabetes from Asia & the West Indies” Pract. Diabetes, 1986; 3:190-192.DOI: https://doi.org/10.1002/pdi.1960030406
5. Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, Velez GG, “The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies” J Clin Epidemiol, 2007; Jun; 60(6):554-9. DOI: https://doi.org/10.1016/j.jclinepi.2006.07.009
6. Altemimi A, Lakhssassi N, Baharlouei A, Watson DG, Lightfoot DA, “Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts” Plants (Basel), 2017; Sep 22:6(4):42. https://doi.org/10.3390/plants6040042
7. Taylor J, Rabe T, McGaw L. et al., “Towards the scientific validation of traditional medicinal plants” Plant Growth Regulation, 2001; 34: 23–37. https://doi.org/10.1023/A:1013310809275
8. Zubair M, Tousif MI, Riaz N, Saleem M, Nazir M, Tauseef S, Abd_Allah EF, “In vitro antioxidant and in silico enzyme inhibition studies of Carissa carandas Linn. Potential ingredient for nutraceutical development” International Journal of Food Properties, 2024; 27(1):1–26. https://doi.org/10.1080/10942912.2024.2409122
9. Horyomba Siaka Ouandaogo, Souleymane Diallo, Eddy Odari, and Johnson Kinyua, “Phytochemical Screening and GC-MS Analysis of Methanolic and Aqueous Extracts of Ocimum kilimandscharicum Leaves” ACS Omega, 2023; 8 (50), 47560-47572. DOI:https://doi.org/10.1021/acsomega.3c05554
10. Kim HY, Moon JY, & Cho SK, “Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells” Journal of medicinal food, 2023; 26(3), 201–210. https://doi.org/10.1089/jmf.2022.K.0061
11. Tan KN, Carrasco-Pozo C, McDonald TS, Puchowicz M, & Borges K, “Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function” Journal of cerebral blood flow and metabolism, 2017; 37(6), 2035–2048. https://doi.org/10.1177/0271678X16659498
12. Misra D, Ghosh NN, Mandal M, Mandal V, Baildya N, Mandal S, & Mandal V, “Anti-enteric efficacy and mode of action of tridecanoic acid methyl ester isolated from Monochoria hastata (L.) Solms leaf” Brazilian journal of microbiology, 2022; 53(2), 715–726. https://doi.org/10.1007/s42770-022-00696-3
13. Rossi A, Martins MP, Bitencourt TA, Peres NTA, Rocha CHL, Rocha FMG, Neves-da-Rocha J, Lopes MER, Sanches PR, Bortolossi JC, & Martinez-Rossi NM, “Reassessing the Use of Undecanoic Acid as a Therapeutic Strategy for Treating Fungal Infections” Mycopathologia, 2021; 186(3), 327–340. https://doi.org/10.1007/s11046-021-00550-4
14. Zhang J, Hu Y, & Wang Z, “Menthol and Its Derivatives: Exploring the Medical Application Potential” Engineering in life sciences, 2025; 25(9), e70039. https://doi.org/10.1002/elsc.70039
15. National Center for Biotechnology Information, PubChem Compound Summary for CID 8175, Decanal. Retrieved April 1, 2026 from https://pubchem.ncbi.nlm.nih.gov/compound/Decanal.
16. McGinty D, Scognamiglio J,Letizia CS, Api AM, “Fragrance material review on 3,5,5-trimethyl-1-hexanol” Food and Chemical Toxicology, 2010; 48(Supplement 4):S47-S50 https://doi.org/10.1016/j.fct.2010.05.026
17. Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot YN, Al-Aizari FA, & Ansar M, “Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review” Molecules, 2018; 23(1), 134. https://doi.org/10.3390/molecules23010134
18. Attia Mohamed I, Aboul-Enein Mohamed N, El-Azzouny Aida A, Maklad, Yousreya A, Ghabbour Hazem A, “Anticonvulsant Potential of Certain New (2E)-2-[1-Aryl-3-(1H-imidazol-1-yl)propylidene]-N-(aryl/H)hydrazinecarboxamides” The Scientific World Journal, 2014;357403:9. https://doi.org/10.1155/2014/357403
19. Locklen Grimsey, Sandy F Van Vuuren, Mitchell Henry Wright, Ian Edwin Cock, “Selected South African Combretum spp. extracts inhibit methicillin-resistant Staphylococcus aureus and ESBL strains of Escherichia coli and Klebsiella pneumonia” South African Journal of Botany, 2024;Volume 165, 49-58,ISSN 0254-6299, https://doi.org/10.1016/j.sajb.2023.12.018
20. Nasr FA, Noman OM, Alqahtani AS, Qamar W, Ahamad, SR, Al-Mishari AA, Alyhya N, & Farooq M, “Phytochemical constituents and anticancer activities of Tarchonanthus camphoratus essential oils grown in Saudi Arabia” Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2020; 28(11), 1474–1480. https://doi.org/10.1016/j.jsps.2020.09.013
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Brij Raj Singh; Amita Verma, Vinay Kumar Yadav
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.